That is necessary, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. In other words, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (the legacy report prediction). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're designed to do. This was an advancement nearly no one noticed. However it's going to have profound implications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this area, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech picks). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially before going greater - jeff brown biotech pick. I've been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. But that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous excellent personal companies on the verge of striking the general public markets And I've been working on a brand-new way for you to invest even prior to these companies go public.
This chance has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your spot for free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (last year). And when it comes to tech investing, we leave it to the specialists. The good news is, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing specialists we know (tech predictions). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential development and developing incredible chances for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown genetic sequencing stock. But despite what many readers may believe, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown biotech picks). Losing two months of manufacturing and sales truly affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million systems is remarkable. More importantly, the hold-ups brought on by the pandemic created a lots of pent-up need. And that demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - tech stocks. And that's not my only 5G prediction When I've spoken about 5G in the past, I've described its three various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage 3, 5G services begin to be offered (white house). That's when we begin to see applications working on 5G networks. Think about things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer season. This begins something of a virtuous cycle: Many people do not really care about the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open up a suite of extraordinary applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities going forward will be enormous. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not work correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For years, CRISPR was mainly a niche technology that wasn't well comprehended. And throughout that time, there were really only 3 business operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This whole industry is successfully a greenfield chance.
There's room for numerous companies to exist in this area. brownstone research. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is necessary because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental procedure. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this technology. This was among those developments that nearly nobody noticed. But it's going to have extensive implications for treating illness. And, of course, there will be lots of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly significantly prior to going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - future report review. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. jeff brown top biotech stock 2021. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date since February 2021, however we could not individually verify this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an outstanding point of view on the marketplace. He's constantly on the hunt for new opportunities, and he shares a lot of his finest picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively predicted some of the greatest economic occasions of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it ideal each time, however Jeff Brown's precise predictions have made him legions of devoted followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research uses numerous research services with a wide array of specializations - social media.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - jeff brown top biotech stock 2021. On its website, Brownstone states its mission is to supply retail investors with professional-grade research: "For too long, the finest financial investment research has actually not been readily available to private financiers. It has actually been normally reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. bleeding edge. The mission of Brownstone Research study is to make that type of proprietary research study readily available to any investors aiming to get an edge in the markets. The goal is easy to provide special and rewarding financial investment research found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise serves as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you understand that he has a track record as a King Midas of sorts. exponential growth. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. jeff brown stock picks 2021. might be "the greatest pattern of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 advanced technologies: artificial intelligence and electric vehicles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars ever. It's nothing except the automobile industry's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have been big this year, but the Wall Street machine has been big on hype without much concrete result. Despite an extreme boost in competition over the previous couple of years, Brown still believes Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transport. Basically, this innovation would enable you to lease your car as an autonomous, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large portion of the revenues. It sounds outrageous, but it could be closed than you think.